找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: High-Density Lipoproteins as Biomarkers and Therapeutic Tools; Volume 2. Improvemen Kyung-Hyun Cho Book 2019 Springer Nature Singapore Pte

[復(fù)制鏈接]
查看: 11570|回復(fù): 35
樓主
發(fā)表于 2025-3-21 16:31:45 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools
副標(biāo)題Volume 2. Improvemen
編輯Kyung-Hyun Cho
視頻videohttp://file.papertrans.cn/427/426564/426564.mp4
概述Provides up-to-date information on means of improving HDL.Examines enhancement of HDL functionality by policosanol.Discusses the latest clinical applications of HDL
圖書封面Titlebook: High-Density Lipoproteins as Biomarkers and Therapeutic Tools; Volume 2. Improvemen Kyung-Hyun Cho Book 2019 Springer Nature Singapore Pte
描述This book is the second of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date information is provided on such topics as the tumor regression-promoting and antidiabetic activities of reconstituted HDL containing V156K apolipoprotein A-I, the enhancement of HDL effects by high doses of vitamin C, the benefits derived from incorporation of growth hormones 1 and 2 into rHDL, and the biological functions of omega-3 linolenic acid in rHDL. The enhancement of HDL functionality by policosanol and the resultant benefits are thoroughly examined in a separate section. Readers will also find the latest information on clinical applications of HDL. Here, specific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of inter
出版日期Book 2019
關(guān)鍵詞HDL, High Density Lipoproteins; HDL metabolism; HDL-Cholesterol; human disease; aging process; biomarker;
版次1
doihttps://doi.org/10.1007/978-981-13-7383-1
isbn_softcover978-981-13-7385-5
isbn_ebook978-981-13-7383-1
copyrightSpringer Nature Singapore Pte Ltd. 2019
The information of publication is updating

書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools影響因子(影響力)




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools影響因子(影響力)學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools網(wǎng)絡(luò)公開度




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools被引頻次




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools被引頻次學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools年度引用




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools年度引用學(xué)科排名




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools讀者反饋




書目名稱High-Density Lipoproteins as Biomarkers and Therapeutic Tools讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics
 

0票 0.00%

Better Implies Difficulty
 

1票 100.00%

Good and Satisfactory
 

0票 0.00%

Adverse Performance
 

0票 0.00%

Disdainful Garbage
您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:36:48 | 只看該作者
HDL as Therapeutic Tools,thout any observed toxicity at therapeutic doses (Oda et al. 2006). These reports have demonstrated that rHDL might be utilized as efficient drug and gene delivery vehicles for therapeutic agents, owing to the ability of peripheral cells to acquire HDL core components.
板凳
發(fā)表于 2025-3-22 03:35:39 | 只看該作者
ific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of inter978-981-13-7385-5978-981-13-7383-1
地板
發(fā)表于 2025-3-22 04:36:06 | 只看該作者
High-Density Lipoproteins as Biomarkers and Therapeutic ToolsVolume 2. Improvemen
5#
發(fā)表于 2025-3-22 11:03:18 | 只看該作者
High-Density Lipoproteins as Biomarkers and Therapeutic Tools978-981-13-7383-1
6#
發(fā)表于 2025-3-22 15:29:13 | 只看該作者
7#
發(fā)表于 2025-3-22 18:42:41 | 只看該作者
8#
發(fā)表于 2025-3-22 23:12:29 | 只看該作者
Enhancement of HDL by Policosanol,8) and increased longevity (Mazzotti et al. 2014; Milman et al. 2014). Policosanol (PCO) supplementation is widely used in Central America and Latin America to treat dyslipidemia and manage cardiovascular burden. PCO is mixture of eight aliphatic primary alcohols refined from sugarcane wax (. L.). I
9#
發(fā)表于 2025-3-23 02:08:50 | 只看該作者
10#
發(fā)表于 2025-3-23 07:17:44 | 只看該作者
Book 2019he changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 23:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
财经| 高青县| 伊春市| 建水县| 同江市| 高雄县| 莎车县| 保康县| 沧源| 鹤山市| 房产| 扎鲁特旗| 陆丰市| 榆社县| 商城县| 太白县| 宁海县| 昭觉县| 搜索| 铅山县| 眉山市| 麻江县| 丹东市| 松溪县| 巢湖市| 溧阳市| 南康市| 杭锦旗| 建德市| 乌拉特中旗| 班玛县| 千阳县| 霞浦县| 正定县| 南郑县| 察隅县| 英德市| 洪泽县| 绥江县| 上蔡县| 拉萨市|